These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6368426)

  • 21. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis.
    Katoch K; Singh P; Adhikari T; Benara SK; Singh HB; Chauhan DS; Sharma VD; Lavania M; Sachan AS; Katoch VM
    Vaccine; 2008 Feb; 26(9):1228-34. PubMed ID: 18243430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
    Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
    Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
    Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term follow up of patients with multibacillary leprosy and HIV infection.
    Jacob M; George S; Pulimood S; Nathan N
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):392-5. PubMed ID: 9030104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ms-ELISA for detection of serum antibody level in leprosy patient--establishment of Ms-ELISA].
    Wu QX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):451-5. PubMed ID: 2978406
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of protein antigens for early serological diagnosis of leprosy.
    Duthie MS; Goto W; Ireton GC; Reece ST; Cardoso LP; Martelli CM; Stefani MM; Nakatani M; de Jesus RC; Netto EM; Balagon MV; Tan E; Gelber RH; Maeda Y; Makino M; Hoft D; Reed SG
    Clin Vaccine Immunol; 2007 Nov; 14(11):1400-8. PubMed ID: 17898185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semi-quantitative detection of Mycobacterium leprae antigens in skin scrapings: suitability as a laboratory aid for field diagnosis of leprosy.
    Chaturvedi V; Girdhar BK; Sengupta U; Sinha S
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):699-706. PubMed ID: 17445850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of leprosy into multibacillary and paucibacillary groups: an analysis.
    Parkash O
    FEMS Immunol Med Microbiol; 2009 Jan; 55(1):1-5. PubMed ID: 19040664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to mycobacterial arabinomannan in leprosy: correlation with reactional states and variation during treatment.
    Miller RA; Harnisch JP; Buchanan TM
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):133-9. PubMed ID: 6373624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen.
    Simonney N; Chavanet P; Perronne C; Leportier M; Revol F; Herrmann JL; Lagrange PH
    Tuberculosis (Edinb); 2007 Mar; 87(2):109-22. PubMed ID: 17030018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
    Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of Mycobacterium leprae recombinant 18,000 MW epitopes by IgG subclasses in leprosy.
    Hussain R; Menz B; Dockrell HM; Chiang TJ
    Immunology; 1995 Feb; 84(2):290-7. PubMed ID: 7538491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient contact is the major determinant in incident leprosy: implications for future control.
    van Beers SM; Hatta M; Klatser PR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):119-28. PubMed ID: 10472363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serologic response to mycobacterial proteins in hansen's patients during multidrug treatment.
    Rada E; Aranzazu N; Ulrich M; Convit J
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):414-21. PubMed ID: 10700916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus- 1 in leprosy patients attending Kenyatta National Hospital, Nairobi.
    Munyao TM; Bwayo JJ; Owili DM; Ndinya-Achola JO; Kwasa TO; Kreiss JK
    East Afr Med J; 1994 Aug; 71(8):490-2. PubMed ID: 7867537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG response to some mycobacterial antigens in selected leprosy patients.
    Rafi A
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):567-71. PubMed ID: 10437959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.